Shou-Ching Tang

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Metastatic Breast Cancer

Combination Therapy

Polycystic Ovary Syndrome

Top Venues

Cancer metastasis reviews

JCO precision oncology

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yating Wang, Shou-Ching Tang
The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options. Cancer metastasis reviews (2022)
Carrie S Wynn, Shou-Ching Tang
Anti-HER2 therapy in metastatic breast cancer: many choices and future directions. Cancer metastasis reviews 41 (1) (2022)
Firas Kreidieh, Ramses F Sadek, Li Fang Zhang, Aaron Gopal, Jean-Pierre Blaize, David Yashar, Reena Patel, Hiral S Patel, Shou-Ching Tang, Houssein Abdul Sater
Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center. JCO precision oncology 6 (2022)
Shou-Ching Tang, Carter L Capra, Germame H Ajebo, Judith Meza-Junco, Simon Mairs, Barbara S Craft, Xiaofu Zhu, Nita Maihle, William B Hillegass
Systemic toxicities of trastuzumab-emtansine predict tumor response in HER2+ metastatic breast cancer. International journal of cancer (2021)